WE DETECT ALZHEIMER'S DISEASE EARLY
At Cognitact, we are translating cutting-edge research efforts into a risk prediction, diagnostic, and disease monitoring tool for dementia, aiming to detect Alzheimer's disease before its symptomatic stage using blood.
What is Alzheimer's Disease (AD) ?
An age-related, progressive chronic disease that affects populations worldwide mainly after the age of 65 - changes occur in the brain
20 years before clinical onset.
Major symptoms include:
Why do we need to early intervention of AD?
-
Patients are diagnosed too late: disease appears many years before actual diagnosis ⇨ miss the golden period for treatment
Early intervention delays the onset of AD!
Our Service
We provide:
-
Risk prediction for AD
-
Assisting AD diagnosis
-
Suggestion for AD risk management
Accuracy up to 96%
Our Mission
We are aspired to enable the public to receive more convenient and accurate predictions and diagnoses in neurodegenerative diseases. We hope to bring forth the next generation of Alzheimer's disease prediction and diagnostic tools for everyone through translating big data discoveries into molecular diagnostics.
Contact Us
Thank you for your interest in our research.
Get in touch with us for any questions or comments regarding our work and publications.
Our location: Office 208, 2/F, Building 17W, Hong Kong Science Park,
Shatin, N.T., Hong Kong, China
Email: info@cognitact.com
Phone: +852 2116-1678